12 Month Price Forecast For MODD
Distance to MODD Price Forecasts
MODD Price Momentum
🤔 Considering Modular Medical (MODD)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: January 22, 2025 7:26 PM UTC
MODD Analyst Ratings & Price Targets
Based on our analysis of 4 Wall Street analysts, MODD has a consensus that is bullish. The median price target is $8.00, with forecasts ranging from $8.00 to $8.00. Currently, there are 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With MODD currently trading at $1.19, the median price forecast suggests a 572.3% upside. The most optimistic forecast comes from at , projecting a 572.3% upside, while at provides the most conservative target, suggesting a 572.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MODD Analyst Consensus
MODD Price Target Range
Latest MODD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MODD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 21, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Reiterates | $5.00 |
| Sep 19, 2023 | Oppenheimer | Steven Lichtman | Outperform | Reiterates | $3.50 |
| Jun 30, 2023 | Benchmark | Bruce Jackson | Speculative Buy | Reiterates | $5.00 |
| May 19, 2023 | Oppenheimer | Steven Lichtman | Outperform | Maintains | $3.50 |
| Jan 30, 2023 | Benchmark | Bruce Jackson | Speculative Buy | Maintains | $5.00 |
| Apr 8, 2022 | Lake Street | Brooks O'Neil | Buy | Initiates | $11.00 |
| Mar 25, 2022 | Benchmark | Speculative Buy | Initiates | $0.00 |
Stocks Similar to Modular Medical, Inc.
The following stocks are similar to Modular Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Modular Medical, Inc. (MODD) Financial Data
Modular Medical, Inc. has a market capitalization of $48.17M with a P/E ratio of -1.6x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -182.6%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Modular Medical, Inc. (MODD) Company Overview
About Modular Medical, Inc.
Medical device company specializing in insulin pumps.
The company designs, develops, and commercializes innovative insulin pumps, specifically targeting individuals with type-1 and type-2 diabetes. It generates revenue through the sale of its flagship product, the MODD1, a two-part patch pump, catering to a growing market of diabetes management.
Headquartered in San Diego, California, Modular Medical aims to improve the quality of life for diabetes patients through advanced medical technology.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
39
CEO
Country
United States
IPO Year
2020
Website
modular-medical.comModular Medical, Inc. (MODD) Latest News & Analysis
Modular Medical partners with Nudge BG to develop an adaptive closed-loop Automated Insulin Delivery system, led by AID expert Lane Desborough.
Modular Medical's partnership with Nudge BG to develop an advanced insulin delivery system could enhance its market position, attract investment, and drive revenue growth in the healthcare sector.
Modular Medical, Inc. (Nasdaq:MODD) will host a conference call on December 5, 2024, at 10:00 a.m. ET to discuss business updates related to its insulin delivery technology.
The upcoming conference call could reveal key insights into Modular Medical's performance and future strategies, impacting investor sentiment and stock valuation.
Modular Medical Announces Proposed Public Offering
2 months agoModular Medical (NASDAQ:MODD) has launched an underwritten public offering of its common stock, including a 30-day option for underwriters to buy up to 15% more shares.
Modular Medical's public offering may dilute existing shares, impacting stock value. The success of the offering could signal investor confidence in its growth potential.
Modular Medical, Inc. has priced a public offering of 5,450,573 shares of common stock, led by existing institutional investors, to support its insulin delivery technology.
Modular Medical's stock offering may dilute existing shares but signals confidence from institutional investors, potentially impacting market perception and future funding for growth initiatives.
Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today (ADEPT) Conference
2 months agoModular Medical (NASDAQ:MODD) is a Gold sponsor of the ADEPT Conference on November 12-13, 2024, aimed at promoting health equity in diabetes care, organized by the American Diabetes Association and T1D Exchange.
Modular Medical's sponsorship of the ADEPT Conference highlights its commitment to diabetes care, potentially enhancing brand visibility and investor confidence in its market positioning and growth prospects.
Modular Medical CEO Jeb Besser will present at a webinar on November 11, 2024, discussing GLP-1 weight loss treatments amid rising diabetes linked to obesity.
The link between obesity and diabetes highlights a growing market for GLP-1 drugs, while high discontinuation rates raise concerns about long-term demand. Modular Medical's innovations could address these issues.
Frequently Asked Questions About MODD Stock
What is Modular Medical, Inc.'s (MODD) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Modular Medical, Inc. (MODD) has a median price target of $8.00. The highest price target is $8.00 and the lowest is $8.00.
Is MODD stock a good investment in 2025?
According to current analyst ratings, MODD has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.19. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MODD stock?
Wall Street analysts predict MODD stock could reach $8.00 in the next 12 months. This represents a 572.3% increase from the current price of $1.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Modular Medical, Inc.'s business model?
The company designs, develops, and commercializes innovative insulin pumps, specifically targeting individuals with type-1 and type-2 diabetes. It generates revenue through the sale of its flagship product, the MODD1, a two-part patch pump, catering to a growing market of diabetes management.
What is the highest forecasted price for MODD Modular Medical, Inc.?
The highest price target for MODD is $8.00 from at , which represents a 572.3% increase from the current price of $1.19.
What is the lowest forecasted price for MODD Modular Medical, Inc.?
The lowest price target for MODD is $8.00 from at , which represents a 572.3% increase from the current price of $1.19.
What is the overall MODD consensus from analysts for Modular Medical, Inc.?
The overall analyst consensus for MODD is bullish. Out of 4 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $8.00.
How accurate are MODD stock price projections?
Stock price projections, including those for Modular Medical, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
